Trial Profile
Open Study of the Effect of Repeated Doses of YF476 on Pentagastrin-induced Gastric Acid Output in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Netazepide (Primary)
- Indications Gastric cancer; Gastritis
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Trio Medicines
- 18 Apr 2015 New trial record